These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36295892)

  • 41. Nitisinone arrests ochronosis and decreases rate of progression of Alkaptonuria: Evaluation of the effect of nitisinone in the United Kingdom National Alkaptonuria Centre.
    Ranganath LR; Khedr M; Milan AM; Davison AS; Hughes AT; Usher JL; Taylor S; Loftus N; Daroszewska A; West E; Jones A; Briggs M; Fisher M; McCormick M; Judd S; Vinjamuri S; Griffin R; Psarelli EE; Cox TF; Sireau N; Dillon JP; Devine JM; Hughes G; Harrold J; Barton GJ; Jarvis JC; Gallagher JA
    Mol Genet Metab; 2018 Sep; 125(1-2):127-134. PubMed ID: 30055994
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early-onset ocular ochronosis in a girl with alkaptonuria (AKU) and a novel mutation in homogentisate 1,2-dioxygenase (HGD).
    Gucev ZS; Slaveska N; Laban N; Danilovski D; Tasic V; Pop-Jordanova N; Zatkova A
    Prilozi; 2011; 32(1):305-11. PubMed ID: 21822197
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Calculi and intracellular ochronosis in the submandibular tissues from a patient with alkaptonuria.
    Taylor AM; Wilson PJ; Ingrams DR; Helliwell TR; Gallagher JA; Ranganath LR
    J Clin Pathol; 2010 Feb; 63(2):186-8. PubMed ID: 20154043
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term follow-up of alkaptonuria patients: single center experience.
    Bozaci AE; Yazici H; Canda E; Uçar SK; Guvenc MS; Berdeli A; Habif S; Coker M
    J Pediatr Endocrinol Metab; 2022 Jul; 35(7):913-923. PubMed ID: 35671204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ochronotic pigmentation is caused by homogentisic acid and is the key event in alkaptonuria leading to the destructive consequences of the disease-A review.
    Ranganath LR; Norman BP; Gallagher JA
    J Inherit Metab Dis; 2019 Sep; 42(5):776-792. PubMed ID: 31282009
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatobiliary circulation and dominant urinary excretion of homogentisic acid in a mouse model of alkaptonuria.
    Norman BP; Sutherland H; Wilson PJM; Rutland DA; Milan AM; Hughes AT; Davison AS; Khedr M; Jarvis JC; Gallagher JA; Bou-Gharios G; Ranganath LR
    J Inherit Metab Dis; 2024 Jul; 47(4):664-673. PubMed ID: 38487984
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alkaptonuria: clinical manifestations and an updated approach to treatment of a rare disease.
    Roopnarinesingh RC; Donlon NE; Reynolds JV
    BMJ Case Rep; 2021 Dec; 14(12):. PubMed ID: 34876442
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Revisiting Quantification of Phenylalanine/Tyrosine Flux in the Ochronotic Pathway during Long-Term Nitisinone Treatment of Alkaptonuria.
    Ranganath LR; Hughes AT; Davison AS; Khedr M; Imrich R; Rudebeck M; Olsson B; Norman BP; Bou-Gharios G; Gallagher JA; Milan AM
    Metabolites; 2022 Sep; 12(10):. PubMed ID: 36295821
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Twelve novel HGD gene variants identified in 99 alkaptonuria patients: focus on 'black bone disease' in Italy.
    Nemethova M; Radvanszky J; Kadasi L; Ascher DB; Pires DE; Blundell TL; Porfirio B; Mannoni A; Santucci A; Milucci L; Sestini S; Biolcati G; Sorge F; Aurizi C; Aquaron R; Alsbou M; Lourenço CM; Ramadevi K; Ranganath LR; Gallagher JA; van Kan C; Hall AK; Olsson B; Sireau N; Ayoob H; Timmis OG; Sang KH; Genovese F; Imrich R; Rovensky J; Srinivasaraghavan R; Bharadwaj SK; Spiegel R; Zatkova A
    Eur J Hum Genet; 2016 Jan; 24(1):66-72. PubMed ID: 25804398
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Founder effects of the homogentisate 1,2-dioxygenase (HGD) gene in a gypsy population and mutation spectrum in the gene among alkaptonuria patients from India.
    Danda S; Mohan S; Devaraj P; Dutta AK; Nampoothiri S; Yesodharan D; Phadke SR; Jalan AB; Thangaraj K; Verma IC; Danda D; Jebaraj I
    Clin Rheumatol; 2020 Sep; 39(9):2743-2749. PubMed ID: 32212000
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of an in vitro model to investigate joint ochronosis in alkaptonuria.
    Tinti L; Taylor AM; Santucci A; Wlodarski B; Wilson PJ; Jarvis JC; Fraser WD; Davidson JS; Ranganath LR; Gallagher JA
    Rheumatology (Oxford); 2011 Feb; 50(2):271-7. PubMed ID: 20952450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Homogentisate 1,2 dioxygenase is expressed in human osteoarticular cells: implications in alkaptonuria.
    Laschi M; Tinti L; Braconi D; Millucci L; Ghezzi L; Amato L; Selvi E; Spreafico A; Bernardini G; Santucci A
    J Cell Physiol; 2012 Sep; 227(9):3254-7. PubMed ID: 22105303
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Natural history of alkaptonuria revisited: analyses based on scoring systems.
    Ranganath LR; Cox TF
    J Inherit Metab Dis; 2011 Dec; 34(6):1141-51. PubMed ID: 21748407
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exacerbation of the ochronosis of alkaptonuria due to renal insufficiency and improvement after renal transplantation.
    Introne WJ; Phornphutkul C; Bernardini I; McLaughlin K; Fitzpatrick D; Gahl WA
    Mol Genet Metab; 2002; 77(1-2):136-42. PubMed ID: 12359141
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alkaptonuria in France: past experience and lessons for the future.
    Aquaron RR
    J Inherit Metab Dis; 2011 Dec; 34(6):1115-26. PubMed ID: 21927854
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of para-Hydroxyphenylpyruvate Dioxygenase by Analogues of the Herbicide Nitisinone As a Strategy to Decrease Homogentisic Acid Levels, the Causative Agent of Alkaptonuria.
    Laschi M; Bernardini G; Dreassi E; Millucci L; Geminiani M; Braconi D; Marzocchi B; Botta M; Manetti F; Santucci A
    ChemMedChem; 2016 Apr; 11(7):674-8. PubMed ID: 26947423
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Natural history of alkaptonuria.
    Phornphutkul C; Introne WJ; Perry MB; Bernardini I; Murphey MD; Fitzpatrick DL; Anderson PD; Huizing M; Anikster Y; Gerber LH; Gahl WA
    N Engl J Med; 2002 Dec; 347(26):2111-21. PubMed ID: 12501223
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.